Your browser doesn't support javascript.
loading
Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.
Akiyama, Yutaro; Morioka, Shinichiro; Tsuzuki, Shinya; Yoshikawa, Tomoki; Yamato, Masaya; Nakamura, Hideta; Shimojima, Masayuki; Takakusaki, Mizue; Saito, Sho; Takahashi, Kozue; Sanada, Mio; Komatsubara, Mika; Takebuchi, Kaoru; Yamaguchi, Etsuko; Suzuki, Tetsuya; Shimokawa, Komei; Kurosu, Takeshi; Kawahara, Madoka; Oishi, Kohei; Ebihara, Hideki; Ohmagari, Norio.
Afiliação
  • Akiyama Y; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Morioka S; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku Univers
  • Tsuzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Yoshikawa T; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yamato M; Division of General Internal Medicine and Infectious Diseases, Rinku General Medical Center, Izumisano, Japan.
  • Nakamura H; Division of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus Graduate School of Medicine, Japan.
  • Shimojima M; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Takakusaki M; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Takahashi K; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Sanada M; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Komatsubara M; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Takebuchi K; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Yamaguchi E; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan; Department of Infectious Diseases, Faculty of Medicine, University of Yamanashi, Y
  • Shimokawa K; Division of Pharmacy, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
  • Kurosu T; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawahara M; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Oishi K; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ebihara H; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
J Infect Chemother ; 30(6): 488-493, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38042298

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article